Mr JNA Gibson MD FRCSEd FRCS(Tr & Orth)

Endoscopic Trial PIS

Home | Selected publications | ISSiS | Endoscopic Trial PIS

Patient Information Sheet: Transforaminal endoscopic discectomy (TESS) -v- Microdiscectomy RCT

Version 2, March 2006

 

Patient Information Sheet

 

Randomised Trial of Two Methods of Discectomy

 

You are being invited to take part in a research study.  Before you decide it is important for you to understand why the research is being done and what it will involve.  Please take time to read the following information carefully and discuss it with others if you wish.  Ask us if there is anything that is not clear or if you would like more information.  Take time to decide whether or not you wish to take part.  Thank you for reading this.

 

Consumers for Ethics in Research (CERES) publish a leaflet entitled ‘Medical Research and You’.  This leaflet gives more information about medical research and looks at some questions you may want to ask.  A copy may be obtained from CERES, PO Box 1365, London N16 0BW.

 

 

 

1.  The purpose of the study.

 

The standard method of treatment of a prolapsed (slipped) disc is microdiscectomy.  This is an open procedure performed through a short incision of usually 5-8 cm.  The nerve root is carefully moved out the way.  Generally patients do extremely well but there is some risk of scarring at the site of surgery.  The surgery is done under a general anaesthetic and patients remain in hospital over night.

 

Endoscopic discectomy uses a different route of access to the spine.  A cannula (hollow cylinder of 6.5mm diameter) is inserted and through this is passed an arthroscope (camera tube).  The disc is visualised and the protruding piece excised.  There is generally less scarring and a quicker recovery.  The surgery is done under a local anaesthetic (with the patient sleepy but not asleep) and generally patients are discharged the same day.

 

The aim of the study is to determine which method is better in terms of result and which method has the lowest costs.

 

2.  Why have I been chosen?

 

You have been chosen as we believe that you will benefit from surgery.  We hope to include all patients with straight-forward ‘slipped’ discs presenting for surgery.

 

3.  Do I have to take part?

 

It is up to you to decide whether or not to take part.  If you do decide to take part you will be given this information sheet to keep and be asked to sign a consent form.  If you decide to take part you are still free to withdraw at any time and without giving a reason.  A decision to withdraw at any time, or a decision not to take part, will not affect the standard of care you receive.

 

4.  What will happen to me if I take part?

 

1.    Before surgery you will be asked to complete some questionnaires and

      sign consent forms for the surgery and the study.

2.    You will be admitted to hospital as would be the case for any other operation.  You will be randomised by computer to receive one of the two surgical treatments.  There is no choice by the patient and the allocation will not be changed within the trial by the surgeon.

3.    The two procedures take approximately the same length of time in the operating theatre (approximately 75 minutes).  The surgery will not delay your discharge nor alter your post-operative care.  We anticipate that you would be admitted either the morning of surgery (or day before if you live far away) and be discharged either later that day or the following morning. 

4.    Following surgery you will be reviewed at the out-patient clinic.  You will be asked to complete further assessment forms to see how well you have done (at 6 weeks, 3 months and 1 year)

 

5.  What do I have to do?

 

We do not anticipate any problems following your surgery.  You will be asked to take ‘things’ fairly easy for 10 days, then we will start you on a course of physiotherapy.  You will be able to swim and return to work provided all is well, generally within 6 weeks of treatment.

 

6.  What is the procedure being tested?

 

Endoscopic discectomy is extremely popular in some European Centres.  Indeed 80% of all spinal procedures are performed endoscopically in one clinic in Munich.  We were not using this technique at all in the UK until the summer of 2004 and therefore we feel that its worth should be critically assessed.

 

7.  What are the side effects of any treatment received when taking part?

 

Both surgical procedures have some known risks.  The most serious is that of nerve root injury.  As far as we can tell there is a similar risk with both techniques (<1%) but you should be aware that any nerve injury is liable to be permanent.  Nerve injury generally leads to a loss of power in the foot and numbness, but you should be aware of the remote possibility of bladder paralysis (probably <0.1%). 

 

There are lesser risks of infection (antibiotics given) and tear to the lining of the spinal canal known as a dural leak.  Both of these complications are usually easily treated, but a second surgical procedure might be required.  These risks are similar with the two techniques.

 

The spine is visualized using X-rays during surgery.  Dosages are similar in the two procedures and no additional radiation is given by virtue of the study.

 

8.  What are the possible disadvantages and risks of taking part?

 

Endoscopic discectomy has a lesser track record than microdiscectomy.  There may be a slightly higher rate of recurrent disc prolapse (approximately 2% versus 1%), but this is outweighed by lesser scar formation making a second operation much easier. 

 

9. What are the possible benefits of taking part?

 

We hope that both procedures will help you.  Endoscopic discectomy is performed under local anaesthetic.  Recovery is much quicker and the scar is 7mm long rather than 5-8cm. 

 

10.  What if new information becomes available?

 

If during the course of the trial we were to find out that one procedure was markedly better than the other then we would advise you accordingly.  However, our recent work would suggest that this is not the case and that any benefits of one over the other are probably small, mainly being in relation to relative cost and scarring.

 

11. What happens when the research study stops?

 

We hope that you will be delighted with the results of your surgery.  We would like to follow your care during a two year period and possibly might contact you at 5 and 10 years.

 

12.   What if something goes wrong?

 

If you are harmed by taking part in this research project, there are no special compensation arrangements.  If you are harmed due to someone’s negligence, then you may have grounds for a legal action but you may have to pay for it.  Regardless of this, if you wish to complain, or have any concerns about any aspect of the way you have been approached or treated during the course of this study, the normal National Health Service complaints mechanisms will be available to you.

 

13.    Will my taking part in this study be kept confidential?

 

 All information which is collected about you during the course of the research will be

 kept strictly confidential.  Any information about you which leaves the

 hospital/surgery will have your name and address removed so that you cannot be

 recognised. 

 

Your GP will be notified of your participation in this trial and other medical practitioners not involved in the research, who may be treating you, may also be made aware of the study.

 

14.  What will happen to the results of the research study?

 

The results will be published, probably in the medical journal ‘Spine’.

 

15.   Who is organising and funding the research?

 

Mr Gibson is the primary organiser of this project.  He is not being paid by any third party.  Some research funding to cover administrative costs has been provided by Quadrant Medical Ltd by way of a small grant.  The instruments used in the trial have been bought by Lothian Health.

 

16.  Who has reviewed the study?

 

The study is conducted with the approval of the Lothian Local Research Ethics Committee 03.

 

17.   Who should I contact for further information?

 

Mr JNA Gibson, Consultant Spinal Surgeon, The Royal Infirmary of Edinburgh

0131 242 3474 (Secretary)

 

Independent information may be sought from Mr P Statham, Consultant Neurosurgeon, who is not associated with the study but aware of its aims. He may be contacted at the Dept. of Surgical Neurology, The Western General Hospital, Edinburgh – Tel: 0131 537 1000.

 

 

 

 

Thank you for offering to take part in this trial. 

 

Enter supporting content here